Company Overview
About AOA Dx
AOA Dx (formerly known under a different name) is a molecular diagnostics company developing novel diagnostic tests for earlier and more accurate disease detection, focusing on underserved testing gaps in clinical settings. The company applies innovative biomarker detection approaches to improve diagnostic accuracy in categories where current testing misses significant patient populations or delivers delayed results.
Business Model & Competitive Advantage
AOA Dx's technology platform leverages proprietary antibody-based detection methods and sample processing innovations that enable detection of low-abundance biomarkers in blood or other clinical samples — a key challenge in early disease detection where target molecule concentrations may be too low for conventional assays. The company's diagnostics are designed for integration into clinical laboratory workflows rather than point-of-care settings.
Competitive Landscape 2025–2026
In 2025, AOA Dx operates in the in-vitro diagnostics market, competing alongside established diagnostic companies including Roche Diagnostics, Abbott, Bio-Rad, and emerging molecular diagnostics startups for laboratory testing market share. The diagnostics industry has seen significant innovation investment as liquid biopsy technologies (detecting cancer from blood samples) and multiomics approaches expand the possibility space for non-invasive disease detection. AOA Dx's commercial strategy focuses on clinical validation studies to demonstrate diagnostic performance and building laboratory partnerships for commercialization of its novel testing panels.
Recent Activity
View all →Denver, CO | May 5, 2026 — AOA Dx, Inc. (“AOA”), a diagnostics company focused on transforming the early identification of ovarian cancer, today announced the enrollment of the first participant in its APEX study, a prospective, multi-site study being conducted across the United States and Europe, designed to expand the company’s industry-leading biobank of women […]
Material Event filed 2026-04-28
Quarterly Report filed 2026-04-27
Material Event filed 2026-04-21
Denver, CO | April 20, 2026 — AOA Dx today announced the presentation of two new studies at the American Association for Cancer Research (AACR) Annual Meeting 2026, demonstrating significant advancement toward a non-invasive, blood-based test for the early detection of ovarian cancer in women experiencing signs and symptoms. The company is actively preparing for […]
Material Event filed 2026-04-20
Veteran LC-MS leader to guide platform progression from early development through clinical and regulatory stages.
Proxy Statement filed 2026-04-07
Seasoned diagnostics leader brings deep expertise in product strategy, commercialization, and market access to launch AKRIVIS GD™ for commercial adoption.
Key Differentiators
Strong Challenger
AOA Dx is an established challenger with significant market presence and competitive offerings in Healthcare.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare AOA Dx with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from AOA Dx? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim AOA Dx Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention AOA Dx vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →